
Regulatory Compliance Gap Analyzer
Audit regulatory submissions against FDA requirements and identify compliance gaps instantly
What You Can Do
You can audit entire regulatory submissions against FDA and ICH requirements, automatically generate compliance checklists tailored to submission type and therapeutic area, cross-reference regulatory requirements to actual documentation sections, and flag missing or incomplete elements with remediation guidance. This eliminates weeks of manual back-and-forth with regulators by ensuring submission readiness before handoff.
Features
Analyzes submissions against FDA/ICH guidance and identifies missing or incomplete regulatory elements
Creates submission-type and therapeutic-area-specific compliance checklists (IND, CTA, BLA, safety submissions)
Maps regulatory requirements to actual documentation sections and verifies internal consistency
Flags gaps with specific, actionable steps to resolve each compliance issue
Produces a gap report that confirms submission readiness before regulatory handoff
Handles IND/CTA, BLA/MAA, safety submissions, protocol amendments, and inspection preparation
Automatically extracts and applies current FDA/EMA regulatory requirements to your documents
Generates gap analysis aligned with FDA meeting minutes and documented regulatory concerns
Example Output
Example 1: IND Submission Gap Analysis
Submission Type: IND (Phase 1) Therapeutic Area: Oncology Compliance Score: 78/100
Critical Gaps:
- CMC Section 2.3.2: Manufacturing process validation data incomplete — requires 3 pilot batches minimum per ICH Q7
- Safety Section 1.3: Animal toxicology narrative missing dose justification for NOEL — reference to pivotal study absent
Major Gaps:
- Analytical methods: HPLC method validation SOP referenced but stability protocol incomplete
Remediation Priority: CMC gaps must be resolved before submission; safety narrative can be submitted as amendment within 30 days.
Example 2: BLA Module Review
Submission: CMC Quality Overall Summary Guidance: ICH CTD Module 3
Matched Requirements: 12/15
Missing Elements:
- Module 3.2.S.4.2: Justification of limits for related substances — no equivalence data to Ph.Eur. monograph
- Module 3.2.P.3: Container closure system — mechanical properties data missing; only chemical compatibility shown
Recommended Action: Provide pharmaceutical equivalence report and container closure mechanical testing within 5 business days.
What's Included
- SKILL.md: Complete regulatory compliance gap analyzer instruction file with FDA/ICH guidance integration
- IND/CTA Compliance Checklist Template: Downloadable checklist covering CMC, safety, efficacy, and manufacturing sections
- BLA/MAA Module Mapping Framework: ICH CTD module cross-reference guide with requirement mapping
- Gap Report Template: Structured template for documenting gaps with severity levels and remediation steps
- FDA Guidance Quick-Reference: Summary of key FDA/EMA requirements by submission type and therapeutic area
Who It's For
- Clinical Research Associates (CRAs) — managing IND/CTA submissions and ensuring regulatory compliance before FDA review
- Regulatory Affairs Specialists — validating submission completeness and preparing gap analysis reports for management
- Quality Assurance Managers — auditing manufacturing documentation and CMC sections against FDA guidance
- Biotech/Pharma Project Managers — coordinating pre-submission preparation and tracking compliance remediation timelines
- Medical Writers — verifying that clinical narrative and safety sections meet regulatory requirements before finalization
Best For
- IND and CTA submission audits — Identify compliance gaps before regulatory submission
- BLA and MAA validation — Cross-check product modules against ICH CTD requirements
- Safety reporting submissions — Verify AE narratives, causality assessments, and regulatory notification timelines
- Protocol amendment compliance — Ensure substantial amendments meet FDA guidance requirements
- Pre-submission meeting preparation — Generate gap analysis aligned with FDA feedback and documented concerns
- Inspection readiness — Audit CAPA documentation, training records, and deviation logs against GMP standards







